Investigating the Mechanisms of Hallucinogen-Induced Visions Using 3,4-Methylenedioxyamphetamine (MDA): A Randomized Controlled Trial in Humans

• Matthew J. Baggott ,

  * E-mail: matthew@baggott.net

  Affiliation Addiction and Pharmacology Research Laboratory, California Pacific Medical Center Research Institute, St Luke's Hospital, San Francisco, California, United States of America

  ⨯
• Jennifer D. Siegrist,

  Affiliation Addiction and Pharmacology Research Laboratory, California Pacific Medical Center Research Institute, St Luke's Hospital, San Francisco, California, United States of America

  ⨯
• Gantt P. Galloway,

  Affiliation Addiction and Pharmacology Research Laboratory, California Pacific Medical Center Research Institute, St Luke's Hospital, San Francisco, California, United States of America

  ⨯
• Lynn C. Robertson,

  Affiliations Helen Wills Neuroscience Institute, University of California, Berkeley, California, United States of America, Veterans Administration, Martinez, California, United States of America

  ⨯
• Jeremy R. Coyle,

  Affiliation Addiction and Pharmacology Research Laboratory, California Pacific Medical Center Research Institute, St Luke's Hospital, San Francisco, California, United States of America

  ⨯
• John E. Mendelson

  Affiliation Addiction and Pharmacology Research Laboratory, California Pacific Medical Center Research Institute, St Luke's Hospital, San Francisco, California, United States of America

  ⨯